Cellectar Biosciences, Inc. — Director's Dealing 2025

Feb 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2025-02-14

Reporting Person: Chanan-Khan Asher (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-14	Stock option (right to buy)	$0.29	A	60000	Acquired	2035-02-14	Common Stock (60000)	Direct

Footnotes

F1: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date.